Filter Results:
(53)
Show Results For
- All HBS Web
(53)
- News (6)
- Research (35)
- Events (2)
- Multimedia (1)
- Faculty Publications (14)
Show Results For
- All HBS Web
(53)
- News (6)
- Research (35)
- Events (2)
- Multimedia (1)
- Faculty Publications (14)
- 09 Apr 2014
- Working Paper Summaries
Visualizing and Measuring Software Portfolio Architectures: A Flexibility Analysis
- 2010
- Working Paper
Boundary Spanning in a For-profit Research Lab: An Exploration of the Interface Between Commerce and Academe
By: Christopher C. Liu and Toby E. Stuart
In innovative industries, private-sector companies increasingly are participants in open communities of science and technology. To participate in the system of exchange in such communities, firms often publicly disclose what would otherwise remain private discoveries.... View Details
Keywords: For-Profit Firms; Higher Education; Information Publishing; Innovation and Invention; Science-Based Business; Social and Collaborative Networks; Boundaries; Biotechnology Industry; Pharmaceutical Industry
Liu, Christopher C., and Toby E. Stuart. "Boundary Spanning in a For-profit Research Lab: An Exploration of the Interface Between Commerce and Academe." Harvard Business School Working Paper, No. 11-012, August 2010.
- 01 Nov 2013
- HBS Seminar
Eric Olson, Chief Scientific Officer at Syros Pharmaceuticals
- 14 Mar 2014
- HBS Seminar
Jeremy M. Levin, former President and CEO, Teva Pharmaceutical Industries
- 16 Jul 2013
- Working Paper Summaries
Visualizing and Measuring Enterprise Architecture: An Exploratory BioPharma Case
- Web
Faculty & Advisors | MBA
Centerview in 2009, the firm has been a leading advisor to the global Biopharmaceutical industry most notable representing biotechnology companies on strategic defense. In the period from 2019 to 2021,... View Details
- 27 Sep 2011
- First Look
First Look: September 27
which the ACA was passed and develops estimates of its likely impact on the biopharmaceutical industry. Universal insurance, either through a government-run system or by mandated purchase of private insurance, has been controversial in... View Details
Keywords: Sean Silverthorne
- Web
Academics - Health Care
interests in organizations that provide health care (e.g., hospitals, medical groups, retail clinics) or in firms that partner with, supply, consult to, or invest in such organizations (e.g., payers, biopharmaceutical and device... View Details
- 05 Dec 2017
- First Look
First Look at New Research and Ideas, December 5, 2017
learning from parallel R&D projects in the setting of drug development. Leveraging the biopharmaceutical industry's unique characteristics to overcome barriers to measuring the project-level response to competitor news, I employ a... View Details
Keywords: Sean Silverthorne
- Web
Profiles - MBA
Engineering Fellow and intern at Retro, a friends-only photo journal backed by Thrive Capital and BoxGroup, have further solidified my interest in the intersection of technology and business. Professional goals: I hope to be involved with View Details
- 09 Mar 2023
- Blog Post
African American Student Union Spotlight on Joint Degrees
start a company after receiving funding from the South Park Commons Founder Fellowship, a program designed to support entrepreneurs at the pre-idea stage. Alongside two former colleagues, I co-founded an on-campus rewards platform for... View Details
- Web
Globalization - Faculty & Research
and Louis Wells on foreign investment in emerging markets - helped pave today’s global research path. Supported by eight Global Research Centers that facilitate our contact with global companies and the collection of international data,... View Details
- 14 Mar 2017
- First Look
First Look at New Research, March 14
management consulting services for life science companies. By 2015, the company was expanding beyond the biopharmaceutical industry, offering analytical services to health care systems, like the National... View Details
Keywords: Sean Silverthorne
- 16 Dec 2014
- First Look
First Look: December 16
Stages of Innovation Through the lens of biopharmaceutical contract research organization (CRO) PAREXEL, this case traces the evolution of the firm as it reinvents itself in response to the transformation of the CRO sector from a small,... View Details
Keywords: Sean Silverthorne
- 27 Mar 2012
- First Look
First Look: March 27
R&D productivity and serious profitability concerns among large drug companies as some of their top-selling products face generic competition. With some observers forecasting an overhaul of the View Details
Keywords: Carmen Nobel
- 11 May 2010
- First Look
First Look: May 11
Nestlé's Milk Districts: Case Supplement Ray A. Goldberg and Kerry HermanHarvard Business School Supplement 906-411 Nestlé, as the largest milk company in the world, has a history of economic development, nutrition, health, and food... View Details
Keywords: Martha Lagace
- 11 Sep 2012
- First Look
First Look: September 11
Moreover, we find that relatively higher wages also promote social norms such that coworkers are less (more) likely to collude to steal inventory from their company when relative wages are higher (lower). Our research contributes to an... View Details
Keywords: Sean Silverthorne
- 16 Sep 2016
- News
Gaining Ground on ALS
If you are one of the 17 million people who participated in the ALS Ice Bucket Challenge, the money you raised may be helping to fund a first-of-its kind clinical collaboration between a nonprofit patient/disease advocacy organization and a View Details
- 22 Jul 2014
- First Look
First Look: July 22
Corporate Finance Attracting Long-Term Investors Through Integrated Thinking and Reporting: A Clinical Study of a Biopharmaceutical Company By: Knauer, Andrew, and George Serafeim Abstract—Faced with a large... View Details
Keywords: Sean Silverthorne
- 28 Jul 2015
- First Look
First Look: July 28, 2015
Value at IBM (A)." Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/215059-PDF-ENG Harvard Business School Case 215-079 Transforming Alkermes into a Global Biopharmaceutical Company In the... View Details
Keywords: Carmen Nobel